About Pacific Diabetes Technologies
Pacific Diabetes Technologies is a private company based in Portland, Oregon, incorporated in 2021 in Delaware. It has reported $6,982,533 raised in four offerings on Form D since June 2021.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Oct 6, 2025 | Oct 20, 2025amended Nov 17, 2025 | $3,385,000of $3.5M target | 15 | $225K | Debt, OptionsRule 506(b) | Form D/A ↗1 earlier filing |
| Mar 13, 2025 | Mar 14, 2025 | $2,057,533of $5.0M target | 5 | $411K | EquityRule 506(b) | Form D ↗ |
| Sep 5, 2023 | Sep 13, 2023amended Sep 9, 2024 | $1,540,000of $5.0M target | 17 | $90,588 | Simple Agreement for Future EquityRule 506(b) | Form D/A ↗1 earlier filing |
| Not yet | Jun 2, 2021 | $0of $2.0M target | 0 | — | Options, Simple Agreement for Future EquityRule 506(b) | Form D ↗ |
| Total, four offerings | $6,982,533 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Pacific Diabetes Technologies's Form D filed Nov 17, 2025.
Earlier filings also listed Peter Eckenberg (director, last listed Mar 2025), Mark Huber (director, last listed Mar 2025), Ken Ward (director, last listed Mar 2025), Edward La Cava (director, last listed Mar 2025), Yobie Benjamin (director, last listed Sep 2024) and Thomas Seidel (executive officer and director, last listed Sep 2024).